PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy.
Miller PG, Sperling AS, Mayerhofer C, McConkey ME, Ellegast JM, Da Silva C, Cohen DN, Wang C, Sharda A, Yan N, Saha S, Schluter C, Schechter I, Słabicki M, Sandoval B, Kahn J, Boettcher S, Gibson CJ, Scadden DT, Stegmaier K, Bhatt S, Lindsley RC, Ebert BL.
Miller PG, et al. Among authors: schluter c.
Blood. 2023 Dec 14;142(24):2079-2091. doi: 10.1182/blood.2023020331.
Blood. 2023.
PMID: 37595362
Free PMC article.